Glucose Health Inc
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in… Read more
Glucose Health Inc (GLUC) - Total Assets
Latest total assets as of September 2025: $189.05K USD
Based on the latest financial reports, Glucose Health Inc (GLUC) holds total assets worth $189.05K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Glucose Health Inc - Total Assets Trend (2007–2024)
This chart illustrates how Glucose Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Glucose Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Glucose Health Inc's total assets of $189.05K consist of 93.6% current assets and 6.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.2% |
| Accounts Receivable | $15.89K | 4.9% |
| Inventory | $249.14K | 77.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.29K | 1.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Glucose Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Glucose Health Inc's current assets represent 93.6% of total assets in 2024, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, down from 10.1% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 77.3% of total assets.
Glucose Health Inc Competitors by Total Assets
Key competitors of Glucose Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Glucose Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Glucose Health Inc generates 1.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Glucose Health Inc is currently not profitable relative to its asset base.
Glucose Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.32 | 0.99 | 0.15 |
| Quick Ratio | 0.06 | 0.32 | 0.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-365.32K | $ -3.82K | $ -390.30K |
Glucose Health Inc - Advanced Valuation Insights
This section examines the relationship between Glucose Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.31 |
| Asset Growth Rate (YoY) | -19.2% |
| Total Assets | $322.32K |
| Market Capitalization | $745.03K USD |
Valuation Analysis
Premium Asset Valuation: The market values Glucose Health Inc's assets at a significant premium ( 2.31x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Glucose Health Inc's assets decreased by 19.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Glucose Health Inc (2007–2024)
The table below shows the annual total assets of Glucose Health Inc from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $322.32K | -19.17% |
| 2023-12-31 | $398.77K | -33.33% |
| 2022-12-31 | $598.13K | -48.26% |
| 2021-12-31 | $1.16 Million | +235.48% |
| 2020-12-31 | $344.62K | +56.84% |
| 2019-12-31 | $219.72K | +146.23% |
| 2018-12-31 | $89.23K | +231.35% |
| 2017-12-31 | $26.93K | -18.75% |
| 2016-12-31 | $33.15K | +115.13% |
| 2015-12-31 | $15.41K | -65.01% |
| 2014-12-31 | $44.03K | +72.06% |
| 2013-12-31 | $25.59K | -87.68% |
| 2012-12-31 | $207.68K | -11.13% |
| 2011-12-31 | $233.68K | +166.18% |
| 2010-12-31 | $87.79K | -46.92% |
| 2009-12-31 | $165.39K | -15.02% |
| 2008-12-31 | $194.61K | +144.95% |
| 2007-12-31 | $79.45K | -- |